Antares Therapeutics

Website

Antares Therapeutics, Inc.

3 Investors
Pharmaceutical Drug Delivery
BOSTON, MA

Antares Therapeutics, Inc. is a leading specialty pharmaceutical company focused on the creation and commercialization of innovative drug delivery technologies. With a mission to enhance patient experiences associated with injectable medications, the company develops solutions that significantly improve comfort and convenience for individuals requiring regular treatment.

Products & Team

XYOSTED®

Auto-InjectorSeed

XYOSTED® is an auto-injector specifically designed for testosterone replacement therapy. It enables patients to self-administer their medication efficiently and comfortably, overcoming the common barriers associated with traditional injection methods.

Value Proposition

XYOSTED® significantly reduces the anxiety and discomfort associated with traditional needles, thereby improving patient adherence to their hormone therapy regimen.

Pain Points

Patients experience anxiety and discomfort related to needles, non-compliance due to injection difficulties, and the need for frequent medication administration.

User-friendly auto-injection systemDesigned for at-home useEnhances patient comfort and compliance
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
BOSTON, MA
Primary headquarters

Funding History

Total Raised:
$40.0M
E

Debt Financing, Option to Acquire Offering

Closed
March 2025
$40.0M
Raised
Progress
100%
Raised
$40.0M
Target
$40.0M
#000205904325000001